CN1032309C - 吲哚衍生物 - Google Patents

吲哚衍生物 Download PDF

Info

Publication number
CN1032309C
CN1032309C CN93104036A CN93104036A CN1032309C CN 1032309 C CN1032309 C CN 1032309C CN 93104036 A CN93104036 A CN 93104036A CN 93104036 A CN93104036 A CN 93104036A CN 1032309 C CN1032309 C CN 1032309C
Authority
CN
China
Prior art keywords
alkyl
compound
aryl
ylmethyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN93104036A
Other languages
English (en)
Chinese (zh)
Other versions
CN1082044A (zh
Inventor
J·E·梅卡
J·T·诺瓦考斯基
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp SRL
Original Assignee
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp SRL filed Critical Pfizer Corp SRL
Publication of CN1082044A publication Critical patent/CN1082044A/zh
Application granted granted Critical
Publication of CN1032309C publication Critical patent/CN1032309C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN93104036A 1992-03-05 1993-03-04 吲哚衍生物 Expired - Fee Related CN1032309C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84664092A 1992-03-05 1992-03-05
US846,640 1992-03-05

Related Child Applications (3)

Application Number Title Priority Date Filing Date
CN95118796A Division CN1044910C (zh) 1992-03-05 1995-11-17 吲哚衍生物
CN95118795A Division CN1044909C (zh) 1992-03-05 1995-11-17 吲哚衍生物
CN95118794A Division CN1082815C (zh) 1992-03-05 1995-11-17 吲哚衍生物

Publications (2)

Publication Number Publication Date
CN1082044A CN1082044A (zh) 1994-02-16
CN1032309C true CN1032309C (zh) 1996-07-17

Family

ID=25298499

Family Applications (4)

Application Number Title Priority Date Filing Date
CN93104036A Expired - Fee Related CN1032309C (zh) 1992-03-05 1993-03-04 吲哚衍生物
CN95118794A Expired - Fee Related CN1082815C (zh) 1992-03-05 1995-11-17 吲哚衍生物
CN95118796A Expired - Fee Related CN1044910C (zh) 1992-03-05 1995-11-17 吲哚衍生物
CN95118795A Expired - Fee Related CN1044909C (zh) 1992-03-05 1995-11-17 吲哚衍生物

Family Applications After (3)

Application Number Title Priority Date Filing Date
CN95118794A Expired - Fee Related CN1082815C (zh) 1992-03-05 1995-11-17 吲哚衍生物
CN95118796A Expired - Fee Related CN1044910C (zh) 1992-03-05 1995-11-17 吲哚衍生物
CN95118795A Expired - Fee Related CN1044909C (zh) 1992-03-05 1995-11-17 吲哚衍生物

Country Status (30)

Country Link
US (2) US5594014A (OSRAM)
EP (1) EP0629199B1 (OSRAM)
JP (1) JPH07121943B2 (OSRAM)
KR (1) KR0179073B1 (OSRAM)
CN (4) CN1032309C (OSRAM)
AT (1) ATE218566T1 (OSRAM)
AU (1) AU666716B2 (OSRAM)
BR (1) BR9306012A (OSRAM)
CA (1) CA2117643C (OSRAM)
CZ (1) CZ282652B6 (OSRAM)
DE (1) DE69331988T2 (OSRAM)
DK (1) DK0629199T3 (OSRAM)
EG (1) EG20416A (OSRAM)
ES (1) ES2176199T3 (OSRAM)
FI (1) FI930968A7 (OSRAM)
HU (1) HU219489B (OSRAM)
IL (1) IL104941A (OSRAM)
MX (1) MX9301197A (OSRAM)
MY (1) MY109298A (OSRAM)
NO (1) NO302617B1 (OSRAM)
NZ (1) NZ249755A (OSRAM)
PL (1) PL172388B1 (OSRAM)
PT (1) PT629199E (OSRAM)
RU (1) RU2124012C1 (OSRAM)
SK (1) SK281938B6 (OSRAM)
TW (1) TW288010B (OSRAM)
UA (1) UA39866C2 (OSRAM)
WO (1) WO1993018032A1 (OSRAM)
YU (1) YU14893A (OSRAM)
ZA (1) ZA931539B (OSRAM)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US6380233B1 (en) 1992-04-07 2002-04-30 Pfizer Inc Indole derivatives as 5-HT1 agonists
AU670579B2 (en) 1992-04-07 1996-07-25 Pfizer Inc. Indole derivatives as 5-HT1 agonists
HUT75646A (en) * 1993-08-31 1997-05-28 Pfizer 5-arylindole derivatives and pharmaceutical compositions containing them
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9420503D0 (en) * 1994-10-11 1994-11-23 Pfizer Ltd Therapeutic agents
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
EA199800611A1 (ru) 1995-12-29 1999-04-29 Берингер, Ингельхайм Фармасьютиклс, Инк. Производные фенилтиазола с противогерпетическими свойствами
US6288091B1 (en) 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
CA2429850C (en) 2000-11-27 2008-12-30 Pfizer Products Inc. Ep4 receptor selective agonists in the treatment of osteoporosis
AU2002309585B2 (en) * 2001-04-20 2008-01-31 Wyeth Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
ITRM20020255A1 (it) * 2002-05-09 2003-11-10 Polifarma Spa Tautomero enolico dell'acido 3-indolilpiruvico, suoi sali e usi terapeutici.
ES2199086B1 (es) * 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
GB0317229D0 (en) * 2003-07-23 2003-08-27 Pfizer Ltd Improved process
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
CA3166940A1 (en) * 2020-02-04 2021-08-12 Abdelmalik Slassi 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of cns disorders
PL243119B1 (pl) * 2020-04-16 2023-06-26 Univ Jagiellonski Rozpuszczalne w wodzie modyfikowane pochodne aminokwasowe nadające się do leczenia chorób o podłożu neurologicznym oraz zaburzeń psychiatrycznych

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
ZA815541B (en) * 1980-08-12 1983-03-30 Glaxo Group Ltd Heterocyclic compounds
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
KR100215627B1 (ko) * 1990-06-07 1999-08-16 레슬리 제인 에드워즈 치료용 헤테로사이클 화합물
RO111767B1 (ro) * 1990-10-15 1997-01-30 Pfizer Derivati de indol, procedee si intermediari pentru prepararea acestora, compozitii farmaceutice si metoda pentru tratarea unor afectiuni
US5208248A (en) * 1991-01-11 1993-05-04 Merck Sharpe & Dohme, Ltd. Indazole-substituted five-membered heteroaromatic compounds
SK278998B6 (sk) * 1991-02-01 1998-05-06 Merck Sharp & Dohme Limited Deriváty imidazolu, triazolu a tetrazolu, spôsob i
TW263508B (OSRAM) * 1991-02-12 1995-11-21 Pfizer

Also Published As

Publication number Publication date
CN1044910C (zh) 1999-09-01
EP0629199B1 (en) 2002-06-05
FI930968A7 (fi) 1993-09-06
DE69331988D1 (de) 2002-07-11
ES2176199T3 (es) 2002-12-01
CN1082044A (zh) 1994-02-16
ZA931539B (en) 1994-09-05
RU2124012C1 (ru) 1998-12-27
PL172388B1 (pl) 1997-09-30
DE69331988T2 (de) 2002-09-19
RU94040914A (ru) 1996-08-10
MY109298A (en) 1996-12-31
CN1082815C (zh) 2002-04-17
IL104941A0 (en) 1993-07-08
EG20416A (en) 1999-02-28
MX9301197A (es) 1993-09-01
CZ212594A3 (en) 1995-06-14
ATE218566T1 (de) 2002-06-15
CA2117643A1 (en) 1993-09-16
PT629199E (pt) 2002-09-30
CZ282652B6 (cs) 1997-08-13
HU9300593D0 (en) 1993-05-28
CN1136566A (zh) 1996-11-27
IL104941A (en) 1998-06-15
CA2117643C (en) 2000-03-14
NZ249755A (en) 1996-08-27
DK0629199T3 (da) 2002-07-15
SK105294A3 (en) 1995-05-10
AU3733093A (en) 1993-10-05
JPH07121943B2 (ja) 1995-12-25
US5594014A (en) 1997-01-14
JPH07500353A (ja) 1995-01-12
NO943261D0 (no) 1994-09-02
TW288010B (OSRAM) 1996-10-11
US5717102A (en) 1998-02-10
WO1993018032A1 (en) 1993-09-16
SK281938B6 (sk) 2001-09-11
UA39866C2 (uk) 2001-07-16
NO943261L (no) 1994-09-02
EP0629199A1 (en) 1994-12-21
CN1044909C (zh) 1999-09-01
HUT64061A (en) 1993-11-29
BR9306012A (pt) 1997-11-18
NO302617B1 (no) 1998-03-30
KR950700291A (ko) 1995-01-16
CN1136432A (zh) 1996-11-27
CN1136565A (zh) 1996-11-27
HU219489B (hu) 2001-04-28
FI930968A0 (fi) 1993-03-04
KR0179073B1 (ko) 1999-03-20
AU666716B2 (en) 1996-02-22
YU14893A (sh) 1996-05-20

Similar Documents

Publication Publication Date Title
CN1032309C (zh) 吲哚衍生物
RU2095360C1 (ru) Производные индола, их оптические изомеры и фармацевтически приемлемые соли
CN1083443C (zh) 吲哚衍生物
CN1066445C (zh) 芳酰基哌啶衍生物
CN1281459A (zh) 哌啶衍生物
CN1074414C (zh) 作为5-ht1a受体配体的苯并二烷甲胺的吲哚基烷基衍生物
CN1293673A (zh) 用作nmda受体拮抗剂的1－(3－杂芳基丙基－或－丙－2－烯基)－4－苄基哌啶
CN1049349A (zh) 新的2-氧代-3，8-二氮杂螺[4，5]癸烷衍生物，含有这些衍生物的药物配方及其制备方法
CN1784230A (zh) 烟碱性乙酰胆碱受体的正向调节剂
JP2959987B2 (ja) 新規なベンゾジオキサン化合物、それらの製造方法およびそれらを含有する医薬組成物
DE69722020T2 (de) Azaheterocyclylmethyl-derivate von 2,3,8,9-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-on
CN1450995A (zh) 用于治疗青光眼的5－羟基吲唑衍生物
CN1049660C (zh) 苯并吡喃化合物，它们的制备方法和含有它们的药物组合物
CN1136807A (zh) N-取代的氮杂二环庚烷衍生物、它们的制备及应用
US5521209A (en) N-substituted azabicyclo[3.2.0]heptane derivatives as neuroleptics, the preparation and use thereof
CN1043574C (zh) 具有中枢神经系统活性的杂环胺
JP4390772B2 (ja) ベンゾオキサゾール誘導体およびアデノシンレセプターリガンドとしてのその使用
Porcs-Makkay et al. New routes to oxindole derivatives
CN1336925A (zh) 4,5,6和7－吲哚及二氢吲哚衍生物,它们的制备和应用
CN1127501C (zh) 吲哚和2,3－二氢吲哚衍生物、它们的制备及用途
CN1195344A (zh) 作为nmda受体拮抗剂的多环生物碱衍生物
JPH03130216A (ja) 骨吸収抑制剤
CN1022243C (zh) 吲哚衍生物的制备方法
CN1188478A (zh) 氮杂环烷衍生物及其制备和在医疗中的应用
CN1751029A (zh) 2－氨乙基取代的嘧啶－2－酮、环丙烷、吡唑啉、嘧啶和苯并噻唑及其作为尿压素ⅱ和生长激素抑制素5 受体配体的应用

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee